These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Preparation of an amorphous sodium furosemide salt improves solubility and dissolution rate and leads to a faster Tmax after oral dosing to rats. Nielsen LH, Gordon S, Holm R, Selen A, Rades T, Müllertz A. Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):942-51. PubMed ID: 24075980 [Abstract] [Full Text] [Related]
6. Multiple approaches to pharmaceutical polymorphism investigation--a case study. Li H, Kiang YH, Jona J. Eur J Pharm Sci; 2009 Dec 08; 38(5):426-32. PubMed ID: 19748574 [Abstract] [Full Text] [Related]
7. Investigation of properties and recrystallisation behaviour of amorphous indomethacin samples prepared by different methods. Karmwar P, Graeser K, Gordon KC, Strachan CJ, Rades T. Int J Pharm; 2011 Sep 30; 417(1-2):94-100. PubMed ID: 21182910 [Abstract] [Full Text] [Related]
9. Amino acids as co-amorphous stabilizers for poorly water soluble drugs--Part 1: preparation, stability and dissolution enhancement. Löbmann K, Grohganz H, Laitinen R, Strachan C, Rades T. Eur J Pharm Biopharm; 2013 Nov 30; 85(3 Pt B):873-81. PubMed ID: 23537574 [Abstract] [Full Text] [Related]
10. Solid dispersions of itraconazole for inhalation with enhanced dissolution, solubility and dispersion properties. Duret C, Wauthoz N, Sebti T, Vanderbist F, Amighi K. Int J Pharm; 2012 May 30; 428(1-2):103-13. PubMed ID: 22414388 [Abstract] [Full Text] [Related]
14. Effect of different preparation methods on the dissolution behaviour of amorphous indomethacin. Karmwar P, Graeser K, Gordon KC, Strachan CJ, Rades T. Eur J Pharm Biopharm; 2012 Feb 30; 80(2):459-64. PubMed ID: 22019529 [Abstract] [Full Text] [Related]
15. Generation of hydrate forms of paroxetine HCl from the amorphous state: an evaluation of thermodynamic and experimental predictive approaches. Pina MF, Pinto JF, Sousa JJ, Craig DQ, Zhao M. Int J Pharm; 2015 Mar 15; 481(1-2):114-24. PubMed ID: 25592956 [Abstract] [Full Text] [Related]
16. Influence of particle size and preparation methods on the physical and chemical stability of amorphous simvastatin. Zhang F, Aaltonen J, Tian F, Saville DJ, Rades T. Eur J Pharm Biopharm; 2009 Jan 15; 71(1):64-70. PubMed ID: 18703139 [Abstract] [Full Text] [Related]
17. Preparation of roxithromycin-polymeric microspheres by the emulsion solvent diffusion method for taste masking. Gao Y, Cui FD, Guan Y, Yang L, Wang YS, Zhang LN. Int J Pharm; 2006 Aug 02; 318(1-2):62-9. PubMed ID: 16647230 [Abstract] [Full Text] [Related]
18. Different or the same? exploring the physicochemical properties and molecular mobility of celecoxib amorphous forms. Wang M, Aalling-Frederiksen O, Madsen AØ, Jensen KMØ, Jørgensen MRV, Gong J, Rades T, Martins ICB. Int J Pharm; 2024 Aug 15; 661():124470. PubMed ID: 39004294 [Abstract] [Full Text] [Related]